(Q36175758)

12 August 2017

1 reference

title

Immunopathogenesis of Crohn's disease (English)

1 reference

12 August 2017

0 references

Thomas T MacDonald

1

1 reference

12 August 2017

Antonio Di Sabatino

series ordinal

2

1 reference

12 August 2017

John N Gordon

series ordinal

3

1 reference

12 August 2017

publication date

1 July 2005

1 reference

Journal of Parenteral and Enteral Nutrition

12 August 2017

published in

1 reference

12 August 2017

volume

29

1 reference

12 August 2017

issue

4 Suppl

1 reference

12 August 2017

page(s)

S118-24; discussion S124-5, S184-8

1 reference

Inflammatory Bowel Disease

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Recent developments in the immunology of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Mucosal immunity in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

CD4 antibody treatment in patients with active Crohn's disease: a phase 1 dose finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Apoptosis: one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Decreased Bax expression by mucosal T cells favours resistance to apoptosis in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

The immunological and genetic basis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Cytokine-based therapies for Crohn's disease--new paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Optimizing anti-TNF treatment in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Review article: treatment of perianal fistulizing Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Electron microscopy in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Role of the faecal stream in the maintenance of Crohn's colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

The immunology of mucosal models of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Crohn's disease and the NOD2 gene: a role for paneth cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

A Failure of Transforming Growth Factor-β1 Negative Regulation Maintains Sustained NF-κB Activation in Gut Inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Functional variants of OCTN cation transporter genes are associated with Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Genetic variation in DLG5 is associated with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively Up-regulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

Efficacy of a transforming growth factor beta 2 containing nutritional support formula in a murine model of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F01486071050290S4S118

10.1177/01486071050290S4S118

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference